查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1808870

无细胞胎儿DNA检测市场（依产品类型、应用、最终用户、国家及地区）－2025年至2032年全球产业分析、市场规模、市场占有率及预测

Cell-free Fetal DNA Testing Market, By Product Type, By Application, By End-user, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 389 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年无细胞胎儿 DNA 检测市场规模价值 17.8923 亿美元，2025 年至 2032 年的复合年增长率为 6.1%。

无细胞胎儿DNA (cffDNA) 检测市场专注于非侵入性产前检测 (NIPT)，即分析孕妇血液中循环的胎儿DNA小片段。此检测有助于在妊娠早期检测出唐氏症（21三体）、18三体和13三体等染色体异常，从而减少对羊膜穿刺术等风险较高的侵入性操作的需求。早期基因筛检意识的增强、孕妇年龄的提高以及DNA定序技术的进步是推动市场发展的关键因素。

DNA 检测因其安全性、准确性和早期检测能力而日益受到医疗保健提供者的青睐。该市场正在全球扩张，尤其是在北美、欧洲和亚太部分地区。监管支持、个人化医疗的日益普及以及对胎儿性别检测的需求也推动了其成长。然而，高昂的费用和低收入地区的医疗服务受限构成了挑战。此检测通常建议在妊娠 10 週后进行，并广泛应用于高风险妊娠。市场涵盖医院、诊断实验室和专科诊所。

无细胞胎儿DNA检测市场-市场动态

对双胞胎和 IVF 妊娠的非侵入性检测的需求不断增加。

双胞胎和体外受精 (IVF) 怀孕对非侵入性检测的需求不断增长，是游离胎儿DNA (cffDNA) 检测市场的利基驱动因素。传统的筛检方法在多胎妊娠中往往准确度较低，因此 cffDNA 检测成为更安全、更可靠的选择。随着辅助生殖技术 (ART) 的普及，全球双胞胎和 IVF 的怀孕数量正在增加。这些怀孕通常被认为是高风险的，促使医疗保健提供者选择 cffDNA 检测等先进的筛检工具。

这种方法能够以更高的精确度区分单一胎儿和多个胎儿的DNA，这一点尤其重要。此外，有试管婴儿（IVF）背景的准父母通常更积极主动地寻求早期准确的遗传资讯。非侵入性检测还能降低这些敏感妊娠中侵入性操作带来的情绪和身体风险。技术进步提高了游离DNA（cffDNA）检测在复杂妊娠中的敏感度。这项利基需求正在推动游离DNA检测服务的更广泛应用和发展。

无细胞胎儿DNA检测市场—关键洞察

根据我们的研究分析师的分析，预计全球市场在预测期内（2025-2032 年）的年复合成长率约为 6.1%。

根据产品类型细分，预计三体检测将在 2024 年占据最大市场份额

根据应用细分，非整倍体筛检是 2024 年的主要应用

从地区来看，北美是 2024 年最大的收入来源

无细胞胎儿 DNA 检测市场-細項分析：

全球无细胞胎儿 DNA 检测市场根据产品类型、应用、最终用户和地区进行细分。

根据产品类型，市场分为四类：性别检测、亲子鑑定、三体性检测和微缺失检测。在「按检测类型」细分市场中，三体性检测在无细胞胎儿DNA检测市场中占据主导地位。此细分市场专注于识别染色体异常，例如21三体（唐氏症）、18三体症（爱德华兹症候群）和13三体（帕陶氏症候群），这些异常是妊娠期间检测出的最常见且最严重的遗传疾病。

早期、准确、非侵入性筛检的临床重要性及其需求推动了该领域占据主导地位。三体综合征检测被广泛推荐用于高风险妊娠，并且在许多国家通常纳入医疗保险范围，进一步支持了其广泛应用。 NGS技术的进步提高了检测的灵敏度和特异性，使其成为可靠的选择。随着产前筛检意识的不断增强，该领域在全球检测量和市场份额方面继续保持领先地位。

根据应用，市场分为四类：非整倍体筛检、胎儿性别鑑定和遗传性疾病检测。在「按应用」细分市场中，非整倍体筛检在无细胞胎儿DNA检测市场中占据主导地位。非整倍体是指细胞中存在异常数量的染色体，这可能导致严重的遗传性疾病，例如唐氏症、爱德华兹氏症候群和帕陶氏症候群。随着孕妇年龄的增长和高龄妊娠中染色体异常风险的增加，对早期和准确筛检的需求显着增加。 cffDNA检测是一种非侵入性、高灵敏度且特异的方法，最早可在妊娠第10週检测出这些异常。

医疗保健提供者更倾向于这种筛检，以避免羊膜穿刺术等侵入性操作带来的併发症。此外，许多已开发地区的政府和保险公司支持非整倍体筛检的报销，从而提高了可近性。早期识别非整倍体对改善妊娠管理的临床重要性，使该应用成为整体市场成长的关键驱动力。随着技术的不断进步和更广泛的应用，预计该领域将在未来几年保持领先地位。

无细胞胎儿DNA检测市场—地理洞察

北美在游离胎儿DNA (cffDNA) 检测市场占据领先地位，这得益于先进的医疗基础设施、对产前筛检的强烈认知以及非侵入性检测技术的广泛应用。美国凭藉较高的孕妇年龄、优惠的报销政策以及 Natera、Labcorp 和 Illumina 等主要市场参与者的参与，在该区域市场占据主导地位。此外，美国也受益于高风险怀孕率以及 cffDNA 检测作为第一级筛检方法的广泛临床接受度。

加拿大透过政府支持的产前计画以及公立和私立医疗机构日益普及的基因检测，做出了巨大贡献。两国新一代定序平台的推出和支援性监管框架的完善，进一步推动了这一成长。此外，患者对早期胎儿健康洞察的偏好日益增长，以及个人化医疗的兴起，也持续扩大了市场规模。北美在游离DNA（cffDNA）检测领域的创新、研究和商业化方面依然处于领先地位。

无细胞胎儿 DNA 检测市场 - 竞争格局：

无细胞胎儿DNA (cffDNA) 检测市场的竞争格局以创新驱动策略为标誌，主要参与者专注于提升检测准确性、全球覆盖范围和临床应用。 Illumina、Natera、Roche 和 Labcorp 等公司以专有技术和经过验证的检测产品引领市场。检测灵敏度竞争激烈，尤其是在双胞胎和试管受精等复杂怀孕情况下。为提升服务的可近性，与医院和诊断实验室建立策略合作伙伴关係、进行收购和合作已成为常态。许多参与者正在投资人工智慧资料分析，以提升对基因的洞察。

华大基因等亚太地区的区域企业也凭藉着高性价比的产品获得了关注。监管审批和报销政策进一步塑造了市场动态。直接面向消费者的基因检测的兴起，促使一些公司开发了患者友善平台。整体而言，市场呈现全球巨头与敏捷新创公司交织的局面，它们透过创新、临床可靠性和市场渗透力竞争。

最新动态：

2025年1月，Ravgen公司在美国联邦巡迴法院赢得了一项关键裁决，该裁决驳回了其对Labcorp公司提起的长期专利侵权诉讼。法院的判决有利于Ravgen公司，可能导致其获得超过4亿美元的赔偿，这凸显了非侵入性产前检测市场中智慧财产权的高风险性。

目录

第一章：无细胞胎儿DNA检测市场概述

  • 研究范围
  • 市场估计年限

第二章：执行摘要

  • 市场片段
    • 无细胞胎儿 DNA 检测市场（依产品类型）
    • 无细胞胎儿 DNA 检测市场片段（依应用）
    • 无细胞胎儿 DNA 检测市场（依最终用户）
    • 无细胞胎儿DNA检测市场（按国家/地区）
    • 无细胞胎儿DNA检测市场（按地区）
  • 竞争洞察

第三章：无细胞胎儿DNA检测主要市场趋势

  • 无细胞胎儿DNA检测市场驱动因素
    • 市场驱动因素的影响分析
  • 无细胞胎儿DNA检测市场限制
    • 市场限制的影响分析
  • 无细胞胎儿DNA检测市场机会
  • 无细胞胎儿DNA检测市场未来趋势

第四章：无细胞胎儿DNA检测产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第五章：无细胞胎儿DNA检测市场：地缘政治紧张局势升级的影响

  • COVID-19 疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：无细胞胎儿DNA检测市场格局

  • 2024年无细胞胎儿DNA检测市占率分析
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第七章：无细胞胎儿DNA检测市场－依产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • 性别测试
    • 亲子鑑定
    • 三体性检测
    • 微缺失检测

第 8 章：无细胞胎儿 DNA 检测市场 - 按应用

  • 概述
    • 按应用细分市场占有率分析
    • 非整倍体筛检
    • 胎儿性别鑑定
    • 遗传疾病检测

第九章：无细胞胎儿DNA检测市场－依最终用户

  • 概述
    • 按最终用户细分的份额分析
    • 医院
    • 诊断实验室
    • 产科诊所
    • 研究中心

第 10 章：无细胞胎儿 DNA 检测市场 - 按地区划分

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美无细胞胎儿DNA检测主要製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模和预测（按应用）
    • 北美市场规模及预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲无细胞胎儿DNA检测主要製造商
    • 欧洲市场规模及预测（按国家/地区）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模和预测，按应用
    • 欧洲市场规模及预测（按最终用户）
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区胎儿无细胞DNA检测主要製造商
    • 亚太地区市场规模及预测（依国家）
    • 亚太地区市场规模及预测（依产品类型）
    • 亚太地区市场规模及预测（按应用）
    • 亚太地区市场规模及预测（依最终用户）
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲无细胞胎儿DNA检测主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模及预测（依产品类型）
    • 拉丁美洲市场规模及预测（按应用）
    • 拉丁美洲市场规模及预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲（MEA）
    • 概述
    • 中东和非洲的无细胞胎儿DNA检测主要製造商
    • MEA 市场规模及预测（依国家/地区）
    • MEA 市场规模及预测（依产品类型）
    • MEA 市场规模及预测（按应用）
    • MEA 市场规模及预测（依最终用户）
    • 沙乌地阿拉伯
    • 阿联酋
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其余地区

第 11 章：主要供应商分析-无细胞胎儿 DNA 检测产业

  • 竞争仪錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • Illumina, Inc.
    • Natera, Inc.
    • Laboratory Corporation of America Holdings (Labcorp)
    • F. Hoffmann-La Roche Ltd
    • Quest Diagnostics Incorporated
    • BGI Genomics Co., Ltd.
    • Eurofins Scientific
    • Myriad Genetics, Inc.
    • Thermo Fisher Scientific Inc.
    • PerkinElmer, Inc.
    • Agilent Technologies, Inc.
    • Centogene NV
    • GE Healthcare
    • MedGenome Labs Ltd.
    • Yourgene Health
    • Genetron Holdings Limited
    • Progenity, Inc.
    • Invitae Corporation
    • Ariosa Diagnostics (a Roche company)
    • Bio-Rad Laboratories, Inc

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV5534

Cell-free Fetal DNA Testing Market size was valued at US$ 1,789.23 Million in 2024, expanding at a CAGR of 6.1% from 2025 to 2032.

The Cell-free Fetal DNA (cffDNA) Testing market focuses on non-invasive prenatal testing (NIPT) that analyzes small fragments of fetal DNA circulating in a pregnant woman's blood. This test helps detect chromosomal abnormalities such as Down syndrome (trisomy 21), trisomy 18, and trisomy 13 early in pregnancy, reducing the need for riskier invasive procedures like amniocentesis. The growing awareness about early genetic screening, rising maternal age, and advancements in DNA sequencing technology are key market drivers.

Healthcare providers increasingly prefer DNA testing due to its safety, accuracy, and early detection capabilities. The market is expanding globally, particularly in North America, Europe, and parts of Asia-Pacific. Regulatory support, increasing adoption of personalized medicine, and demand for fetal gender testing also contribute to its growth. However, high costs and limited access in low-income regions pose challenges. The test is typically recommended after 10 weeks of gestation and is widely used in high-risk pregnancies. The market encompasses hospitals, diagnostic labs, and specialty clinics.

Cell-free Fetal DNA Testing Market- Market Dynamics

Rising demand for non-invasive testing in twin and IVF pregnancies.

A niche driver for the Cell-free Fetal DNA (cffDNA) Testing market is the rising demand for non-invasive testing in twin and in vitro fertilization (IVF) pregnancies. Traditional screening methods often show reduced accuracy in multiple pregnancies, making cffDNA testing a safer and more reliable option. With the increasing use of assisted reproductive technologies (ART), the number of twin and IVF pregnancies is growing globally. These pregnancies are generally considered high-risk, prompting healthcare providers to opt for advanced screening tools like cffDNA testing.

The ability of this method to differentiate fetal DNA from multiple fetuses with higher precision is particularly valuable. Moreover, expectant parents from IVF backgrounds are often more proactive in seeking early and accurate genetic information. Non-invasive tests also reduce the emotional and physical risks associated with invasive procedures in these sensitive pregnancies. Technological advancements have improved the sensitivity of cffDNA tests in complex pregnancies. This niche demand is contributing to the broader adoption and development of cffDNA testing services.

Cell-free Fetal DNA Testing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.1% over the forecast period (2025-2032)

Based on product type segmentation, Trisomy Detection was predicted to show maximum market share in the year 2024

Based on application segmentation, Aneuploidy Screening was the leading application in 2024

Based on region, North America was the leading revenue generator in 2024

Cell-free Fetal DNA Testing Market- Segmentation Analysis:

The Global Cell-free Fetal DNA Testing Market is segmented on the basis of Product Type, Application, End-user, and Region.

The market is divided into four categories based on product type: Gender Testing, Paternity Testing, Trisomy Detection, and Microdeletion Testing. Within the "By Test Type" segment, Trisomy Detection is the most dominant in the Cell-free Fetal DNA Testing market. This segment focuses on identifying chromosomal abnormalities such as Trisomy 21 (Down syndrome), Trisomy 18 (Edwards syndrome), and Trisomy 13 (Patau syndrome), which are among the most common and serious genetic conditions detected during pregnancy.

The high clinical importance and demand for early, accurate, and non-invasive screening drive the dominance of this segment. Trisomy detection is widely recommended for high-risk pregnancies and is often covered by insurance in many countries, further supporting its widespread use. Technological advancements in NGS have improved detection sensitivity and specificity, making it a reliable choice. As awareness of prenatal screening grows, this segment continues to lead in test volume and market share globally.

The market is divided into four categories based on application: Aneuploidy Screening, Fetal Sex Determination, and Genetic Disorder Detection. Among the "By Application" segments, Aneuploidy Screening is the most dominant in the Cell-free Fetal DNA Testing market. Aneuploidy refers to the presence of an abnormal number of chromosomes in a cell, which can lead to serious genetic disorders such as Down syndrome, Edwards syndrome, and Patau syndrome. The increasing maternal age and higher risk of chromosomal abnormalities in older pregnancies have significantly driven the demand for early and accurate screening. cffDNA testing offers a non-invasive, highly sensitive, and specific method to detect these abnormalities as early as the 10th week of gestation.

Healthcare providers prefer this screening to avoid the complications associated with invasive procedures like amniocentesis. Additionally, governments and insurance companies in many developed regions support reimbursement for aneuploidy screening, enhancing accessibility. The clinical importance of identifying aneuploidies early for better pregnancy management has positioned this application as the key driver of overall market growth. With ongoing technological advancements and broader adoption, this segment is expected to maintain its lead in the coming years.

Cell-free Fetal DNA Testing Market- Geographical Insights

North America holds a leading position in the Cell-free Fetal DNA (cffDNA) Testing market, driven by advanced healthcare infrastructure, strong awareness about prenatal screening, and widespread adoption of non-invasive testing technologies. The United States dominates the regional market due to high maternal age, favorable reimbursement policies, and the presence of major market players like Natera, Labcorp, and Illumina. The U.S. also benefits from a high rate of high-risk pregnancies and broad clinical acceptance of cffDNA tests as a first-tier screening method.

Canada contributes significantly through government-backed prenatal programs and increasing use of genetic testing in both public and private healthcare sectors. The availability of next-generation sequencing platforms and supportive regulatory frameworks in both countries has further fueled growth. In addition, rising patient preference for early fetal health insights and the shift toward personalized medicine continue to expand the market. North America remains at the forefront of innovation, research, and commercialization in the cffDNA testing space.

Cell-free Fetal DNA Testing Market- Competitive Landscape:

The competitive landscape of the Cell-free Fetal DNA (cffDNA) Testing market is marked by innovation-driven strategies, with key players focusing on expanding test accuracy, global reach, and clinical applications. Companies like Illumina, Natera, Roche, and Labcorp lead the market with proprietary technologies and validated test offerings. Intense competition exists in test sensitivity, especially for complex pregnancies such as twins and IVF cases. Strategic partnerships, acquisitions, and collaborations with hospitals and diagnostic labs are common to enhance service accessibility. Many players are investing in AI-powered data analysis to improve genetic insights.

Regional players in Asia-Pacific, such as BGI Genomics, are also gaining traction through cost-effective offerings. Regulatory approvals and reimbursement policies further shape market dynamics. The rise in direct-to-consumer genetic testing has led some firms to develop patient-friendly platforms. Overall, the market reflects a blend of global giants and agile startups competing through innovation, clinical reliability, and market penetration.

Recent Developments:

In January 2025, Ravgen won a key ruling at the U.S. Federal Circuit in its long-standing patent infringement case against Labcorp. The court's decision, favoring Ravgen, may result in an award of damages exceeding $400 million, highlighting the high-stakes nature of intellectual property within the non-invasive prenatal testing market

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CELL-FREE FETAL DNA TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Illumina, Inc.
  • Natera, Inc.
  • Laboratory Corporation of America Holdings (Labcorp)
  • F. Hoffmann-La Roche Ltd
  • Quest Diagnostics Incorporated
  • BGI Genomics Co., Ltd.
  • Eurofins Scientific
  • Myriad Genetics, Inc.
  • Thermo Fisher Scientific Inc.
  • PerkinElmer, Inc.
  • Agilent Technologies, Inc.
  • Centogene N.V.
  • GE Healthcare
  • MedGenome Labs Ltd.
  • Yourgene Health
  • Genetron Holdings Limited
  • Progenity, Inc.
  • Invitae Corporation
  • Ariosa Diagnostics (a Roche company)
  • Bio-Rad Laboratories, Inc.

GLOBAL CELL-FREE FETAL DNA TESTING MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Gender Testing
  • Paternity Testing
  • Trisomy Detection
  • Microdeletion Testing

GLOBAL CELL-FREE FETAL DNA TESTING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Aneuploidy Screening
  • Fetal Sex Determination
  • Genetic Disorder Detection

GLOBAL CELL-FREE FETAL DNA TESTING MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Diagnostic Laboratories
  • Maternity Clinics
  • Research Centers

GLOBAL CELL-FREE FETAL DNA TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Cell-free Fetal DNA Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Cell-free Fetal DNA Testing Market Snippet by Product Type
    • 2.1.2. Cell-free Fetal DNA Testing Market Snippet by Application
    • 2.1.3. Cell-free Fetal DNA Testing Market Snippet by End-user
    • 2.1.4. Cell-free Fetal DNA Testing Market Snippet by Country
    • 2.1.5. Cell-free Fetal DNA Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Cell-free Fetal DNA Testing Key Market Trends

  • 3.1. Cell-free Fetal DNA Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cell-free Fetal DNA Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cell-free Fetal DNA Testing Market Opportunities
  • 3.4. Cell-free Fetal DNA Testing Market Future Trends

4. Cell-free Fetal DNA Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cell-free Fetal DNA Testing Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Cell-free Fetal DNA Testing Market Landscape

  • 6.1. Cell-free Fetal DNA Testing Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cell-free Fetal DNA Testing Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Gender Testing
    • 7.1.3. Paternity Testing
    • 7.1.4. Trisomy Detection
    • 7.1.5. Microdeletion Testing

8. Cell-free Fetal DNA Testing Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Aneuploidy Screening
    • 8.1.3. Fetal Sex Determination
    • 8.1.4. Genetic Disorder Detection

9. Cell-free Fetal DNA Testing Market - By End-user

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-user, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Diagnostic Laboratories
    • 9.1.4. Maternity Clinics
    • 9.1.5. Research Centers

10. Cell-free Fetal DNA Testing Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Cell-free Fetal DNA Testing Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Cell-free Fetal DNA Testing Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Cell-free Fetal DNA Testing Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Cell-free Fetal DNA Testing Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Cell-free Fetal DNA Testing Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Cell-free Fetal DNA Testing Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Illumina, Inc.
    • 11.2.2. Natera, Inc.
    • 11.2.3. Laboratory Corporation of America Holdings (Labcorp)
    • 11.2.4. F. Hoffmann-La Roche Ltd
    • 11.2.5. Quest Diagnostics Incorporated
    • 11.2.6. BGI Genomics Co., Ltd.
    • 11.2.7. Eurofins Scientific
    • 11.2.8. Myriad Genetics, Inc.
    • 11.2.9. Thermo Fisher Scientific Inc.
    • 11.2.10. PerkinElmer, Inc.
    • 11.2.11. Agilent Technologies, Inc.
    • 11.2.12. Centogene N.V.
    • 11.2.13. GE Healthcare
    • 11.2.14. MedGenome Labs Ltd.
    • 11.2.15. Yourgene Health
    • 11.2.16. Genetron Holdings Limited
    • 11.2.17. Progenity, Inc.
    • 11.2.18. Invitae Corporation
    • 11.2.19. Ariosa Diagnostics (a Roche company)
    • 11.2.20. Bio-Rad Laboratories, Inc

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us